Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy
- Status
- RECRUITING
- Phase
- NA
A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa
- Status
- RECRUITING
- Phase
- N/A
Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer
- Status
- RECRUITING
- Phase
- NA
Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
- Status
- RECRUITING
- Phase
- PHASE3
Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.
- Status
- RECRUITING
- Phase
- NA
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma
- Status
- AVAILABLE
- Phase
- N/A